Skip to main content
BetterLife Pharma logo

BetterLife Pharma — Investor Relations & Filings

Ticker · BETR ISIN · CA08772P2026 CSE Professional, scientific and technical activities
Open in API
Filings indexed 632 across all filing types
Latest filing 2023-04-25 Regulatory Filings
Country CA Canada
Listing CSE BETR

About BetterLife Pharma

https://abetterlifepharma.com/

BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing novel, patient-friendly compounds to treat neuro-psychiatric and neurological disorders, addressing significant unmet mental health needs. The company's core strategy involves revolutionizing brain health by producing non-hallucinogenic medicines. Its lead product candidate is 2-Bromo-LSD (BETR-001), a second-generation lysergic acid diethylamide (LSD) derivative. BETR-001 is designed to mimic the projected therapeutic properties of LSD, acting as a potent neuroplastogen, but without causing psychedelic effects or incurring the high regulatory hurdles associated with Schedule 1 controlled substances. BETR-001 is being developed as a potential therapy for debilitating conditions such as treatment-resistant depression, PTSD, anxiety, and cluster headaches.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-04-25 English
News release - English.pdf
Investor Presentation Classification · 90% confidence The document is a press release announcing that BetterLife Pharma Inc. will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference. It contains no financial statements, no detailed financial data, no regulatory filings, no voting results, no management changes, no audit information, and no report attachments. It is an announcement about an upcoming investor presentation event, not the presentation itself or a financial report. Therefore, the document best fits the category of Investor Presentation (IP) announcement, but since it is only announcing the presentation and not providing the presentation materials, it is not a full Investor Presentation. However, given the available categories, the closest fit is Investor Presentation (IP) as it relates to investor-focused presentation content. Confidence is high because the document clearly focuses on an investor conference presentation announcement.
2023-04-20 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions on filing reports related to exempt distributions of securities in Canada. It includes definitions, filing instructions, security codes, and regulatory references specific to exempt distribution reporting. There is no financial performance data, earnings information, or management discussion. The document is a regulatory form used for reporting exempt distributions rather than a financial report or announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and filings that do not fit other specific categories.
2023-03-29 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing that an article about BetterLife Pharma's drug candidate BETR-001 was published in a scientific journal. It discusses the drug's development status, preclinical studies, and future plans for clinical trials. There are no financial statements, regulatory filings, or detailed financial data. The content is primarily a corporate announcement about scientific progress and publication, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a presentation, call transcript, or governance-related document. The best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2023-03-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a media article coverage about BetterLife Pharma's drug candidate BETR-001 and its potential for treating mood disorders. It contains no financial data, no regulatory filing references, no meeting materials, no voting results, no management or board changes, no earnings or interim reports, no audit or legal proceedings information, and no capital or share issuance updates. It is a general corporate announcement about scientific progress and media coverage. Therefore, it does not fit into any specific financial or regulatory filing category. The best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories. The document length is 5294 characters, which is sufficient for a substantive announcement but not a formal report.
2023-03-22 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event involving the closing of a brokered private placement and a non-brokered private placement by BetterLife Pharma Inc. It includes specifics about the number of units issued, prices, warrants, related party transactions, and exemptions under Canadian securities laws. The document is a regulatory filing reporting a material change event, specifically a financing transaction, but it is not a full financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive details of the transaction itself. The document fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The length (15,000 characters) and detailed content support this classification with high confidence.
2023-03-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.